The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 06, 2025
Filed:
Nov. 02, 2016
Applicant:
Ac Immune SA, Lausanne, CH;
Inventors:
Gergana Galabova, Vienna, AT;
Sabine Schmidhuber, Vienna, AT;
Achim Schneeberger, Vienna, AT;
Arne Von Bonin, Vienna, AT;
Dorian Winter, Vienna, AT;
Jana Zimmermann, Vienna, AT;
Assignee:
AC Immune SA, Lausanne, CH;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61P 25/16 (2005.12); A61K 39/00 (2005.12); A61P 37/06 (2005.12);
U.S. Cl.
CPC ...
A61K 39/0008 (2012.12); A61K 39/0005 (2012.12); A61K 39/0007 (2012.12); A61P 25/16 (2017.12); A61P 37/06 (2017.12); A61K 2039/545 (2012.12); A61K 2039/55505 (2012.12); A61K 2039/577 (2012.12); A61K 2039/6037 (2012.12); A61K 2039/6081 (2012.12); A61K 2039/627 (2012.12);
Abstract
Disclosed is a method for vaccination against a self-antigen in a human patient wherein a dose with an effective amount of a self-antigen is administered to the patient to elicit a primary immune response, characterised in that the patient is subjected to a boost administration of said self-antigen, wherein the amount of the self-antigen in the dose for the boost administration is higher than the amount of the self-antigen in the dose used in the administration for the primary immune response.